Absence of gastrointestinal bleeding with controlled-release potassium chloride tablets.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001241:Aspirin / Q000009:adverse effects; D002860:Chromium Radioisotopes; D003692:Delayed-Action Preparations; D005243:Feces; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011189:Potassium Chloride / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D002860:Chromium Radioisotopes; D003692:Delayed-Action Preparations; D010919:Placebos; D011189:Potassium Chloride; D001241:Aspirin